A Second-Half Story: Medicare Plans, Wall Street and the Future of Part D
This article was originally published in RPM Report
Executive Summary
The three most aggressive Medicare Part D bidders are thrilled with how their bets are paying off so far. The next challenge: translating market share into profits and proving to investors that they can make Medicare pay in the long term.
You may also be interested in...
Medicare Market Shares: Why the Big Plans Don't Mind Losing Ground
United and Humana remain by far the biggest players in the stand-alone drug insurance market for Medicare, but the field is gaining on them. They don't seem to mind. Is that a sign that the market is "mature"? Or a warning of rocky times ahead for a critical program for pharma.
Medicare Market Shares: Why the Big Plans Don't Mind Losing Ground
United and Humana remain by far the biggest players in the stand-alone drug insurance market for Medicare, but the field is gaining on them. They don't seem to mind. Is that a sign that the market is "mature"? Or a warning of rocky times ahead for a critical program for pharma.
Preparing for Year Two of Part D: CMS Puts a Premium on Stability
The bids are in for insurers participating in the 2007 Medicare plan year. A last-minute rules change by CMS likely means fewer changes in the market for the second year.